Targeting Reward-Relevant Nicotinic Receptors in the Discovery of Novel Pharmacotherapeutic Agents to Treat Tobacco Dependence

Ítems similars

• Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-picolinium)-12-triethylammonium-dodecane dibromide (TMPD)
  per: Dwoskin, Linda P., et al.
  Publicat: (2007)
• Novel bis-, tris-, and tetrakis-tertiary amino analogues as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release
  per: Zhang, Zhenfa, et al.
  Publicat: (2010)
• Bis-azaaromatic quaternary ammonium salts as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release: An investigation of binding conformation
  per: Zheng, Guangrong, et al.
  Publicat: (2007)
• tetrakis-Azaaromatic quaternary ammonium salts: Novel subtype-selective antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release
  per: Zhang, Zhenfa, et al.
  Publicat: (2008)
• Targeting Nicotinic Receptor Antagonists as Novel Pharmacotherapies for Tobacco Dependence and Relapse
  per: Dwoskin, Linda P., et al.
  Publicat: (2009)